
FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs.
On April 10, the U.S. Food and Drug Administration (FDA) released a strategic roadmap to phase out the requirement for animal testing in the preclinical evaluation of monoclonal antibodies (mAbs) and other drugs.